Using Inside-Out Open Innovation to Recover Abandoned Pharmaceutical Compounds

Pharmaceutical drug development costs have risen rapidly over the past twenty years.  However, the number of new molecular entities being approved has not increased.  As pharmaceutical companies scale back their R&D in light of this deteriorating productivity, significant unmet medical needs rem...

Full description

Bibliographic Details
Main Authors: Henry Chesbrough, Eric L. Chen
Format: Article
Language:English
Published: Universidade do Porto, Faculdade de Engenharia (FEUP) 2015-07-01
Series:Journal of Innovation Management
Subjects:
Online Access:https://journalsojs3.fe.up.pt/index.php/jim/article/view/280